While studies show that inhibition of OCT4- and NANOG-associated proteins can reduce their expression, more studies are needed to analyze the effect of direct inhibition of OCT4 and NANOG separately in ovarian cancer. The gene discussed is NANOG; the disease is ovarian carcinoma.